Suppr超能文献

大肠杆菌中一种新型甘氨酰胺核糖核苷酸转甲酰基酶的证据。

Evidence for a novel glycinamide ribonucleotide transformylase in Escherichia coli.

作者信息

Nygaard P, Smith J M

机构信息

Institute of Biological Chemistry B, University of Copenhagen, Denmark.

出版信息

J Bacteriol. 1993 Jun;175(11):3591-7. doi: 10.1128/jb.175.11.3591-3597.1993.

Abstract

We demonstrate here that Escherichia coli synthesizes two different glycinamide ribonucleotide (GAR) transformylases, both catalyzing the third step in the purine biosynthetic pathway. One is coded for by the previously described purN gene (GAR transformylase N), and a second, hitherto unknown, enzyme is encoded by the purT gene (GAR transformylase T). Mutants defective in the synthesis of the purN- and the purT-encoded enzymes were isolated. Only strains defective in both genes require an exogenous purine source for growth. Our results suggest that both enzymes may function to ensure normal purine biosynthesis. Determination of GAR transformylase T activity in vitro required formate as the C1 donor. Growth of purN mutants was inhibited by glycine. Under these conditions GAR accumulated. Addition of purine compounds or formate prevented growth inhibition. The regulation of the level of GAR transformylase T is controlled by the PurR protein and hypoxanthine.

摘要

我们在此证明,大肠杆菌合成两种不同的甘氨酰胺核糖核苷酸(GAR)转甲酰酶,二者均催化嘌呤生物合成途径的第三步。一种由先前描述的purN基因编码(GAR转甲酰酶N),另一种迄今未知的酶由purT基因编码(GAR转甲酰酶T)。分离出了在purN和purT编码酶合成方面有缺陷的突变体。只有两个基因均有缺陷的菌株生长需要外源嘌呤来源。我们的结果表明,这两种酶可能都起到确保正常嘌呤生物合成的作用。体外测定GAR转甲酰酶T活性需要甲酸作为C1供体。purN突变体的生长受到甘氨酸的抑制。在这些条件下,GAR积累。添加嘌呤化合物或甲酸可防止生长抑制。GAR转甲酰酶T水平的调节由PurR蛋白和次黄嘌呤控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8007/204760/2712c1832176/jbacter00053-0359-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验